Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coherent Investments
Suzhou, Jiangsu, China
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Coherent Biopharma is a clinical-stage biotechnology company based in Suzhou, China, specializing in the development of next-generation targeted cancer therapeutics. The company utilizes its proprietary BEST™ (Bi-Engaging ligand-mediated Selective Targeting) platform to create Bi-XDC (Bi-specific drug conjugates) and Peptide-Drug Conjugates (PDCs) that target multiple receptors on tumor cells simultaneously. Its lead candidate, CBP-1008, is a first-in-class bi-targeting ligand-drug conjugate currently in Phase 3 clinical trials for platinum-resistant ovarian cancer. Coherent Biopharma aims to address "undruggable" targets and improve the therapeutic index of cytotoxic agents through precise, multi-targeted delivery.
- Therapeutic areas
- Oncology
- Modalities
- Peptide-drug conjugateBi-specific drug conjugateLigand-targeted drug conjugateSmall molecule
- Industry
- Biotech
02
Partnerships
MultiValent BiotherapiesRoche DiagnosticsC-Ray TherapeuticsWuXi STA
Beyond the preview
Go deeper on Coherent Investments.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Coherent Investments.